Michael Rankin, MD, a board-certified Internal Medicine physician, or Kristina Dino, Board Certified Nurse Practitioner
According to the UK Summary of Product Characteristics (SmPC), nausea is classified as a very common side effect, occurring in approximately 16-20% of patients initiating Ozempic therapy
Routine aspiration is no longer recommended by the WHO or CDC for the deltoid, ventrogluteal or vastus lateralis sites, as those sites carry negligible vessel risk
Yesas of July 1, 2026 , Medicare can cover Wegovy for weight loss through the new Medicare GLP-1 Bridge at a flat $50/month , covering all Wegovy formulations (injection and oral tablets)
Again, if there is an unexpected result, it is useful to repeat the test